Preliminary Clinical Study on the Effect of L-ornithine on the Efficacy of Ustekinumab in Patients With Crohn's Disease

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

May 1, 2025

Study Completion Date

September 30, 2025

Conditions
Mild to Severe Crohns Disease
Interventions
DIETARY_SUPPLEMENT

Now Foods L-Ornithine Capsules

L-ornithine is an amino acid that helps the liver clear toxic ammonia and plays an important role in liver protection and treatment of hepatic encephalopathy. Now Foods L-ornithine capsules are an ornithine supplement containing 500mg of L-ornithine per capsule. Patients in the L-ornithine supplementation group take ornithine capsules orally twice a day, three capsules each time, for 8 weeks.

Trial Locations (1)

Unknown

RECRUITING

The Third Xiangya Hospital of Central South University, Changsha

All Listed Sponsors
collaborator

RenJi Hospital

OTHER

lead

The Third Xiangya Hospital of Central South University

OTHER